title: Drug eluting stents for saphenous vein graft interventions.
abstract: Drug eluting stents (DES) have improved percutaneous coronary intervention (PCI) outcomes for most coronary lesion subsets and have gained widespread acceptance. This practice is supported by large-scale clinical trials. Evidence for DES use for treatment of saphenous vein graft (SVG) lesions is less well defined and often conflicting. Most SVG interventions are performed in the setting of an acute coronary syndrome (ACS), in large caliber vascular conduits with soft and friable plaque with inflammatory debris, without a fibrous cap. In this review, we provide an up to date assessment of the published evidence on DES use in PCI of SVG lesions.
authors.affiliation: VA North Texas Healthcare System, Washington, DC, USA. Subhash.banerjee@utsouthwestern.edu
authors.forename: S
authors.initials: S
authors.lastname: Banerjee
authors.forename: R
authors.initials: R
authors.lastname: Master
authors.forename: A
authors.initials: A
authors.lastname: Iqbal
authors.forename: E S
authors.initials: ES
authors.lastname: Brilakis
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000628:therapy; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D054855:Drug-Eluting Stents; D019317:Evidence-Based Medicine; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D012501:Saphenous Vein / Q000637:transplantation*; D016896:Treatment Outcome